Immunovant share price logo

Immunovant

NASDAQ: IMVT

Mid Cap

$33.30

-0.70

(-2.06%)

as on

Immunovant Stock Performance

as on September 26, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $33.17
    $34.22
    downward going graph

    0.39%

    Downside

    2.76%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $15.56
    $45.42
    downward going graph

    53.29%

    Downside

    36.40%

    Upside

    downward going graph

Immunovant share price movements today

Previous Close
$34.00
Open
$34.03
Volume
1.1M
Market Cap
$7.0B
Day's Low - High
$33.17 - $34.22
52 Week Low - High
$15.56 - $45.42

Immunovant Historical Returns

1 Month Return
-24.13 %
3 Month Return
-14.29 %
1 Year Return
+ 105.18 %
3 Year Return
-16.67 %
5 Year Return
+ 284.97 %

Immunovant Stock Fundamentals & Key Indicators

Check Immunovant market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.0B

EPS (TTM)

-2.82

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-12.06

Industry PE ratio

-12.76

PEG Ratio

-18.634687602892388

EBITDA

-538.5M

Revenue (TTM)

7.1M

Profit Margin

97.10%

Return On Equity TTM

-69.59%

Immunovant Stock Valuation

Track how Immunovant P/E has moved over time to understand its valuation trends.

Immunovant in the last 5 years

  • Overview

  • Trends

Lowest (-16.83x)

March 31, 2024

Industry (-12.76x)

March 31, 2026

Today (-8.97x)

March 31, 2026

Highest (-3.86x)

March 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -8.97x

Immunovant vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immunovant with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$7.0B284.97%-12.0697.10%0.00%
Neutral$77.8B-53.76%-24.41-12.57%0.00%
StrongBuy$132.4B186.58%30.1686.04%0.00%
Buy$82.8B23.34%19.0184.86%0.46%

Stock Returns calculator for Immunovant Stock including INR - Dollar returns

The Immunovant stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Immunovant investment value today

Current value as on today

₹2,21,703

Returns

₹1,21,703

(+121.7%)

Returns from Immunovant Stock

₹1,05,176 (+105.18%)

Dollar Impact

₹16,527 (+16.53%)

Analyst Recommendation on Immunovant Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71428571428571% of analysts recommend a 'BUY' rating for Immunovant. Average target price of $48.88

Immunovant Share Price Target

Get share price movements and forecasts by analysts on Immunovant.

What analysts predicted

31.87%UPSIDE

Target Price

$48.88

Current Price

$33.3

Analyzed by

7 Analysts

High

$66

Target

$48.88

Low

$41

Immunovant target price $48.88, a slight upside of 31.87% compared to current price of $33.3. According to 7 analysts rating.

Indian Investors' Interest in Immunovant Stock

Search interest for Immunovant Stock has decreased by -62% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-62% versus previous 30 day period

Immunovant Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
7
Gross Profit
-
-
-
-
-
-
0
0
-
7
Operating Income
-80
-94
-115
-114
-113
-127
-131
-114
-159
-153
EBITDA
-75
-86
-108
-110
-105
-119
-125
-108
-150
-153
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-75
-87
-109
-110
-105
-119
-125
-109
-150
-153
Income Tax Expense
0
0
0
0
0
0
0
1
-2
-
Net Income
-75
-87
-109
-111
-106
-120
-126
-110
-147
-153
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%

Immunovant Annual Profit & Loss

All numbers in Millions USD

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
0
-
-
-
-
-
0
Operating Income
-136
0
-59
-108
-156
-208
-270
-438
-532
EBITDA
-
0
-65
-108
-156
-198
-258
-412
-504
Interest Expense
-
-
0
-
-
12
-
-
-
Depreciation
136
0
0
0
0
0
0
0
0
Income Before Tax
-136
0
-66
-107
-156
-210
-258
-412
-505
Income Tax Expense
-
-
0
0
0
0
0
0
0
Net Income
-136
0
-66
-107
-156
-210
-259
-413
-505
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Immunovant Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-75
-87
-109
-111
-106
-120
-126
-110
-147
-153
Operating Cash Flow
-59
-76
-88
-100
-110
-117
-102
-92
-95
-124
Investing Cash Flow
0
0
0
0
0
-
-
-
0
-
Financing Cash Flow
1
0
0
2
450
2
24
564
3
20
Change in Cash
-55
-75
-87
-98
339
-115
-77
472
-92
-104

Immunovant Annual Cash Flow

All numbers in Millions USD

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Income
-136
-28
-66
-107
-156
-210
-259
-413
-505
Operating Cash Flow
-128
-28
-53
-83
-106
-188
-214
-375
-407
Investing Cash Flow
-
0
0
0
0
0
0
0
0
Financing Cash Flow
128
35
146
383
200
70
472
454
595
Change in Cash
-
6
93
299
93
-117
258
78
188

Mutual Funds that own Immunovant Stock

Check out the Mutual Funds with significant holdings in Immunovant.

Funds
Holdings
Shares Held
Fidelity Mt. Vernon Street Trust
3.69659%
7635408
VANGUARD INDEX FUNDS
3.094432%
6391633
T. ROWE PRICE SMALL-CAP STOCK FUND, INC.
0.724763%
1497019
Fidelity Contrafund
0.648696%
1339901
Prudential Jennison Small Co Fund, Inc.
0.506072%
1045306

Global Institutional Holdings in Immunovant

Funds
Holdings
Fidelity Mt. Vernon Street Trust
3.7%
Vanguard
3.61%
VANGUARD INDEX FUNDS
3.09%
Andrew J.M. Spokes
2.81%
Felix Baker
2.63%

Insights on Immunovant

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 100.0% return, outperforming this stock by 115.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 606.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, IMVT stock has moved down by -9.9%

About Immunovant

Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to advancing novel monoclonal antibody therapies for the treatment of various autoimmune conditions. The company's primary focus is batoclimab, a pioneering, fully human monoclonal antibody. This antibody is engineered to specifically target and block the neonatal fragment crystallizable receptor (FcRn), a key mechanism in certain autoimmune diseases. Batoclimab is currently undergoing Phase IIa clinical evaluations for treating both myasthenia gravis and thyroid eye disease. Additionally, it has commenced Phase II clinical studies for patients suffering from warm autoimmune hemolytic anemia. Established in 2018, Immunovant operates from its headquarters in New York, New York, functioning as a subsidiary under the umbrella of Roivant Sciences Ltd.
OrganisationImmunovant
Headquarters1000 Park Forty Plaza, Durham, NY, 27713, US
IndustryBiotechnology
CEOEric Venker
E-voting on sharesClick here to vote

Key Management of Immunovant

Name

Title

Dr. Frank M. Torti M.B.A., M.D.

Executive Chairperson of the Board

Dr. Eric Venker M.D., Pharm.D.

CEO & Director

Dr. Jay S. Stout M.S., Ph.D.

Chief Technology Officer

Ms. Christine Blodgett

Senior Vice President of Human Resources

Mr. Tiago M. Girao CPA

Chief Financial Officer

Ms. Melanie Gloria B.S.N.

Chief Operating Officer

Mr. Christopher A. Van Tuyl Esq., J.D.

Chief Legal Officer & Corporate Secretary

Ms. Becky Merlina

Senior VP & Global Head of Quality

Ms. Yan Zheng M.S., Ph.D.

Senior Vice President of Biostatistics, Programming & Data Management

Ms. Sheetal Patel M.B.A., M.D., M.S.

Senior Vice President of Clinical Development

FAQs

What is Immunovant share price today?

Immunovant share price today is $33.30 as on at the close of the market. Immunovant share today touched a day high of $34.22 and a low of $33.17.

What is the 52 week high and 52 week low for Immunovant share?

Immunovant share touched a 52 week high of $45.42 on and a 52 week low of $15.56 on . Immunovant stock price today i.e. is closed at $33.30,which is 26.68% down from its 52 week high and 114.07% up from its 52 week low.

What is Immunovant's market capitalisation today?

Immunovant market capitalisation is $0.01T as on .

How to invest in Immunovant Stock (IMVT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immunovant on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immunovant Shares that will get you 0.0450 shares as per Immunovant share price of $33.30 per share as on September 26, 2026 at 8:45 am IST.

What is the minimum amount required to buy Immunovant Stock (IMVT) from India?

Indian investors can start investing in Immunovant (IMVT) shares with as little as ₹95.819999694824 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.20 in Immunovant stock (as per the Rupee-Dollar exchange rate as on ). Based on Immunovant share’s latest price of $33.30 as on September 26, 2026 at 8:45 am IST, you will get 0.3003 shares of Immunovant. Learn more about fractional shares .

What are the returns that Immunovant has given to Indian investors in the last 5 years?

Immunovant stock has given 284.97% share price returns and 29.7% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?